Skip to main content
H.R. 1393 118th Congress House

To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.

Introduced: March 8, 2024 Introduced by: Madeleine Dean Democratic · Pennsylvania See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2023
Referred to the Subcommittee on Health.
Mar 7, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 7, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 17, 2023

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Lobbying activity 7

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 7 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1393: To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1393/
MLA
"H.R. 1393: To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1393/.
Bluebook (legal)
H.R. 1393, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1393/.
Markdown link
[H.R. 1393: To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.](https://openamerica.io/bill/118-HR-1393/)
Report a problem